Expression of HMGCR, SCP2mRNAin hereditary cholesterol gallstone patients

Cui Yun-Feng,Cui Nai-Qiang,Li Dong-Hua,Zhang Ju

DOI: https://doi.org/10.3969/j.issn.1009-3079.2005.09.016

2005-01-01

World Chinese Journal of Digestology

Abstract:AIM: To investigate the expression of the genes for HMGcoA reductase (HMGCR) and sterol carrier protein-2 (SCP2) in the livers of patients with hereditary and non-hereditary cholesterol gallstone, as well as non-cholesterol gallstone. METHODS: The mRNA expression levels of the liver HMGCR and SCP2 genes were determined by RT-PCR in 28 patients with hereditary cholesterol gallstone, 30 patients with non-hereditary cholesterol gallstone, and 32 patients with non-cholesterol gallstone. RESULTS: The mRNA expression levels of HMGCR in hereditary and non-hereditary cholesterol gallstone patients were 1.9 269±0.2 134 and 1.9 791±0.2 524, respectively, both increased significantly (P<0.05) as compared with that in the non-cholesterol gallstone patients (0.7 730±0.1 530). The levels of SCP2 mRNA in hereditary and non-hereditary cholesterol gallstone patients were 0.8 908±0.1 649 and 0.7 503±0.1 004, both increased significantly (P<0.05) as compared with non-cholesterol gallstone patients (0.5 205+0.1 900). Moreover, there was also a significant increase of SCP 2 mRNA in hereditary cholesterol gallstone patients as compared with non-hereditary cholesterol gallstone patients (P<0.05). CONCLUSION: HMGCR and SCP2 are overexpressed in cholesterol gallstone patients, which may be an important cause of cholesterol gallstones.